In A549 lung tumor cells, LPA inhibits P53 activity via LPA1-3 receptor, reduces p53-dependent transcription, promotes loss of p53 protein, and protects tumor cells from actinomycin D-induced apoptosis 89. Here, TP53 is linked to neoplasm.